Early-Stage Breast Cancer Recruiting Phase 2 Trials for Letrozole (DB01006)

IndicationStatusPhase
DBCOND0031560 (Early-Stage Breast Cancer)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03906669A Window of Opportunity Study of Pre-operative Endocrine Therapy With and Without Prometrium in Postmenopausal Women With Early Stage Breast Hormone Receptor Positive (HR+) Human Epidermal Receptor 2 Negative (HER2-) Breast Cancer.Treatment